Business Plan Executive Summary

FINAL FOR RELEASE
Contact: Pamela B. Stewart, Essenza Communications
phone: 303/570-1678
email: [email protected]
FDA HAS “NO FURTHER QUESTIONS” ON MAGTEIN®
AIDP receives final approval from FDA for proprietary ingredient magnesium l-threonate; further
underscores Magtein’ safety for cognitive health and Alzheimer’s disease
City of Industry, CA – (April 2015) – AIDP announces that Magtein, magnesium l-threonate, a patented
compound for cognitive health and Alzheimers Disease, has received a Letter of No Objection from the
Food and Drug Administration, confirming its GRAS (Generally Regarded As Safe) designation. This
milestone means that using Magtein in selected food categories at a level of up to 0.12%. The FDA letter is
available at
http://www.fda.gov/Food/IngredientsPackagingLabeling/GRAS/NoticeInventory/ucm422436.htm.
Magtein™, magnesium l-threonate, is a patented, natural ingredient discovered by MIT professors searching
for novel neurodegenerative disease treatments. For this reason, Magtein was extensively studied in cell
culture, in animal studies for its mechanisms of action, its effects on brain function, as well as its safety.
These results are published in prestigious neurological journals, including Neuron, and supported by top
neurological scientists in the world, including Nobel Prize winners. One reason Magtein has generated so
much interest from consumers is its unique mechanism of action: it restores the neural cells to their healthy,
youthful conditions by blocking background signal activation, while many other brain ingredients/drugs
continue stimulating cells. Recently, a human clinical study using Magtein was performed and preliminary
results indicate a significant improvement in memory and cognition.
“Receiving a GRAS designation from the FDA is a huge step for Magtein,” says Kathy Lund, vice president
of marketing and business development at AIDP. “It allows us to move beyond our current market in dietary
supplements, into the massive food and drink manufacturing industry. Consumers will now potentially be
able to get a wide variety of foods, from baked goods to beverages to processed juices and soups, containing
Magtein, and reap the many health benefits of this form of magnesium.”
Magnesium l-threonate naturally exists in our body and brain. It is an ideal supplement to restore our brain
and body’s magnesium levels to prevent neural degeneration and restore brain function. Recently, top
neuroscientists have shown interest in its ability to treat brain diseases, including Alzheimer’s, Parkinson’s,
ADHD, as well as other immunity related diseases, for the reason that magnesium has been shown to play a
major role in the etiology of these diseases. Several universities, including Stanford, UCLA, and Harvard
are in the process of planning these promising studies. (I feel this paragraph may be too much on the disease
claim).
###
AIDP is a leader in functional ingredients, with a focus on extensively researched products that meet
consumer demand for wellness and healthy aging. Our commitment is to source high-quality ingredients
and provide proprietary solutions that address formulation challenges. AIDP's success is grounded in its
depth of experience and commitment to strong science for functional food and beverage product
development.